Valle Franco
Senior Vice President, Finance at Eidos Therapeutics, Inc.
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jan 12, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Eidos Therapeutics, Inc.Senior Vice President, Finance
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Eidos Therapeutics, Inc.UnusualMar 2, 2020 2020
Sold 3,000 shares at $52.33 ($157k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($157k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Eidos Therapeutics, Inc.UnusualMar 26, 2020 +24 days
Sold 5,000 shares at $48.26 ($241k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($241k position)0 shares leftFiling
- 3 Form 4 sale Eidos Therapeutics, Inc.UnusualApr 20, 2020 +25 days
Sold 2,000 shares at $49.79 ($100k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($100k position)0 shares leftFiling
- 4 Form 4 sale Eidos Therapeutics, Inc.UnusualOct 8, 2020 +171 days
Sold 10,643 shares at $74.97 ($798k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($798k position)0 shares left3.5x usual sizeFiling
- 5 Form 4 sale Eidos Therapeutics, Inc.UnusualNov 9, 2020 +32 days
Sold 1,623 shares at $74.93 ($122k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($122k position)0 shares left0.4x usual sizeFiling
- 6 Form 4 sale Eidos Therapeutics, Inc.UnusualJan 12, 2021 +64 days
Sold 3,247 shares at $125.52 ($408k)
Valle Franco, Senior Vice President, Finance
Sold 100% of holdings ($408k position)0 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2021 | Jan 13, 2021 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 3,247 | $408k | 100.0% | Unusual | SEC |
| Nov 9, 2020 | Nov 10, 2020 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 1,623 | $122k | 100.0% | Unusual | SEC |
| Oct 8, 2020 | Oct 9, 2020 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 10,643 | $798k | 100.0% | Unusual | SEC |
| Apr 20, 2020 | Apr 22, 2020 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 2,000 | $100k | 100.0% | Unusual | SEC |
| Mar 26, 2020 | Mar 30, 2020 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 5,000 | $241k | 100.0% | Unusual | SEC |
| Mar 2, 2020 | Mar 4, 2020 | Eidos Therapeutics, Inc. | Senior Vice President, Finance | Form 4 sale | 3,000 | $157k | 100.0% | Unusual | SEC |